June 7, 2022 by Kevin Ban and Jenni Zilka
AmerisourceBergen, Jen Zilka, Kevin Ban, Walgreens
Leading Headlines, Pharmacy

As we emerge from the COVID-19 pandemic, it is clear that patients have come to rely on and value the accessibility of pharmacies and the clinical services pharmacists provide. This is evidenced by the 253 million doses of COVID-19 vaccines administered by pharmacies this past year, by the Administration’s recent inclusion of pharmacies in the
May 11, 2022 by Chain Drug Review
AmerisourceBergen, WBA
Business, Featured Articles, Leading Headlines, Retail News

DEERFIELD, Ill.– Walgreens Boots Alliance, Inc. (WBA) has sold 6.0 million shares of AmerisourceBergen Corp. common stock pursuant to Rule 144 at a price of $150 per share. After the sale, Walgreens Boots Alliance’s ownership of AmerisourceBergen’s common stock has decreased from approximately 28.1% to approximately 25.2%. The sale has no impact to the long-term
May 3, 2022 by Chain Drug Review
AmerisourceBergen, Bob Mauch
Leading Headlines, Pharmacy

CONSHOHOCKEN, Pa. – AmerisourceBergen (AB) convened leaders and innovators across the biopharmaceutical industry on today for its ThinkLive Commercialization summit, an annual event centered on strategies and solutions that help companies maximize success at every stage of the product lifecycle. During the summit in Las Vegas, leaders discussed the challenges and considerations companies face when
April 21, 2022 by Chain Drug Review
AmerisourceBergen, George Rafferty, Gina Clark
April 25, 2022, Leading Headlines

CONSHOHOCKEN, Pa. — Don’t fear that asking others for help makes you appear weaker, don’t be afraid to let others help you — and trust your instincts. This was the advice that Gina Clark, executive vice president and chief communication and administration officer at AmerisourceBergen (AB), said she would give to her younger self. Gina’s
March 29, 2022 by Chain Drug Review
AmerisourceBergen, Good Neighbor Pharmacy
Leading Headlines, Pharmacy

CONSHOHOCKEN, Pa. — On March 24, 2022, H.R. 7213, the Equitable Community Access to Pharmacist Services Act, was introduced by U.S. Representatives Ron Kind (D-WI), David B. McKinley (R, W. Va.), Earl L. “Buddy” Carter (R, Ga.), and Nanette Diaz Barragán (D, Calif.). The bipartisan legislation ensures patients’ continued access to pandemic-related care services provided
March 7, 2022 by Chain Drug Review
AmerisourceBergen, HDA, Heather Zenk, president of Supply Chain Operations and Distribution Services, with the Distribution Management Award for Industry Leadership
Leading Headlines, Pharmacy

AUSTIN, Texas — The Healthcare Distribution Alliance (HDA) presented Heather Zenk, president of Supply Chain Operations and Distribution Services, AmerisourceBergen, with the Distribution Management Award for Industry Leadership. The award, which recognizes an individual for their exceptional contributions to the pharmaceutical distribution industry, was presented today at the HDA 2022 Distribution Management Conference in Austin,
March 7, 2022 by Chain Drug Review
AmerisourceBergen, HDA
Leading Headlines, Pharmacy

AUSTIN, Texas — The Healthcare Distribution Alliance (HDA) honored AmerisourceBergen with the 2022 Distribution Management Award (DMA) in recognition of the company’s collaboration with multiple government and supply chain partners to enable small-practice provider access to the COVID-19 vaccine. The award was presented during the 2022 Distribution Management Conference and Expo in Austin, Texas. The DMA annually recognizes
February 25, 2022 by Chain Drug Review
AmerisourceBergen, Cardinal Health and McKesson
Leading Headlines, Pharmacy

NEW YORK — AmerisourceBergen, Cardinal Health and McKesson announced Friday that each company has independently determined that there is sufficient participation by states and litigating political subdivisions to proceed with a comprehensive agreement to settle the vast majority of the opioid lawsuits filed by state and local governmental entities. The companies have previously disclosed that
February 17, 2022 by Chain Drug Review
AmerisourceBergen, Ann Anaya
Leading Headlines, Pharmacy

CONSHOHOCKEN, Pa. — As part of AmerisourceBergen’s growing commitment to fostering a diverse and inclusive workplace, the global health care company announced on Thursday the appointment of Ann Anaya as the organization’s SVP and Chief Diversity Equity and Inclusion Officer. In this position, Anaya will lead the Office of Diversity, Equity and Inclusion (DEI) and
October 25, 2021 by Jeffrey Woldt
AmerisourceBergen, Brian Nightengale, Video Forum
Featured Articles, Leading Headlines, Videos

In the second installment of a two-part interview, Brian Nightengale, president of community and specialty pharmacy and long-term care at AmerisourceBergen, discusses where specialty medications fit in the retail landscape and the shifting dynamics in long-term care. In addition, he talks about the reasons he remains optimistic about the future of the pharmacy profession.
October 18, 2021 by Jeffrey Woldt
AmerisourceBergen, Brian Nightengale, Video Forum
Featured Articles, Leading Headlines, Videos

In the first installment of a two-part interview, Brian Nightengale, newly appointed president of community and specialty pharmacy and long-term care at AmerisourceBergen, talks about the company’s Good Neighbor Pharmacy network, the expanded scope of his responsibilities, and Jennifer Zilka, his successor as president of Good Neighbor. In addition, Nightengale offers insights about the slowly
July 20, 2021 by Chain Drug Review
AmerisourceBergen, John Ryan, URAC
Leading Headlines, Pharmacy

WASHINGTON – URAC announced on Tuesday that is has entered into an agreement with global health care company, AmerisourceBergen to provide discounted pricing on URAC accreditation and designation programs, as well as value-added services to AmerisourceBergen’s dispensing provider customers seeking new accreditation. This relationship exemplifies URAC’s continuing goal of improving the quality of health care across the country, by making its meaningful accreditation programs available to
February 22, 2021 by Jeffrey Woldt
AmerisourceBergen, Chain Drug Review's Video Forum, laire Biermaas and vice president of strategic solutions Mike Amante
Featured Articles, Leading Headlines, Videos

In this week’s Video Forum, AmerisourceBergen group vice president of corporate partnerships Claire Biermaas and vice president of strategic solutions Mike Amante discuss the health services company’s efforts to cement its position as an essential partner for its top customers. The executives outline how AmerisourceBergen’s design thinking process results in a shared strategic vision.
February 18, 2021 by Chain Drug Review
AmerisourceBergen, AmerisourceBergen releases 2020 Global Sustainability Report, Gina Clark
Business, Leading Headlines, Supplier News

VALLEY FORGE, Pa. – AmerisourceBergen, a global healthcare company, released its 2020 Global Sustainability Report and ESG Reporting Index, detailing the impact of its robust sustainability and community efforts. This year, AmerisourceBergen made its report available through the launch of a new microsite, which serves as a comprehensive, interactive resource to showcase data, information and